Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the relationship between plasma and intracellular darunavir (DRV) concentrations
and virological efficacy in HIV-infected patients on DRV/rtv monotherapy.